ScPharmaceuticals to Announce First Quarter 2024 Financial Results On Tuesday, May 14, 2024
ScPharmaceuticals to Announce First Quarter 2024 Financial Results On Tuesday, May 14, 2024
Management to host conference call and webcast at 4:30 p.m. ET
管理層將在美國東部時間下午 4:30 主持電話會議和網絡直播
BURLINGTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that scPharmaceuticals management will host a conference call and audio webcast at 4:30 p.m. ET on Tuesday, May 14th, 2024, to discuss the financial results for the first quarter 2024 and provide a business update.
馬薩諸塞州伯靈頓，2024年5月7日（GLOBE NEWSWIRE）——專注於開發和商業化具有優化療法、促進患者護理和降低醫療成本潛力的產品的製藥公司SCPHarmicals Inc.（納斯達克股票代碼：SCPH）今天宣佈，SCPHarmicals管理層將於美國東部時間5月14日星期二下午 4:30 舉辦電話會議和網絡音頻直播第四，2024年，討論2024年第一季度的財務業績並提供業務最新情況。
Participants should dial 1-800-717-1738 (domestic) or 1-646-307-1865 (international) with the conference code 89054.
參與者應撥打 1-800-717-1738（國內）或 1-646-307-1865（國際），會議代碼爲 89054。
To access the Call Me feature, which avoids having to wait for an operator, click here.
要訪問 “給我打電話” 功能，無需等待接線員，請單擊此處。
The live webcast and replay of the conference call can be accessed here or under "News & Events" in the Investor Relations section of the Company's website, .
可以在此處或公司網站投資者關係部分的 “新聞與活動” 下觀看電話會議的網絡直播和重播。
About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company's lead program focuses on the subcutaneous, self-administration of IV-strength treatment in heart failure. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit .
關於 SC 製藥
SCPharmaceuticals是一家制藥公司，專注於開發和商業化旨在降低醫療成本和改善健康狀況的產品。該公司在內部和通過戰略合作伙伴關係開發創新的產品和解決方案，旨在擴大和推進特定急性疾病的門診護理。該公司的牽頭項目側重於心力衰竭的靜脈注射強度治療的皮下自我給藥。scPharmicals總部位於馬薩諸塞州伯靈頓。欲了解更多信息，請訪問。
Katherine Miranda
scPharmaceuticals Inc., 781-301-6869
kmiranda@scpharma.com
凱瑟琳米蘭
SCpharmicals Inc.，781-301-6869
kmiranda@scpharma.com
Investors:
PJ Kelleher
LifeSci Advisors, 617-430-7579
pkelleher@lifesciadvisors.com
投資者：
PJ Kelleher
LifeSci 顧問，617-430-7579
pkelleher@lifesciadvisors.com
譯文內容由第三人軟體翻譯。